Valeant Makes Skin Care Licensing Deal Amid Allergan Offer

Six Am Law 100 firms are advising as Valeant sells the licensing rights to several skin care products to Nestle for $1.4 billion as it ups its unsolicited bid for Botox maker Allergan.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.